enGene is Biotechnology in Canada that focus on mucosal immunotherapy platform business. Founded in 1999. They cover business area such as developer, inflammatory bowel disease, diabetes, a flexible nucleotide delivery technology, mucosal tissue, numerous prevalent, chronic disease, suppression, protein expression level, physician, doctor, physiologic, meal-regulate insulin secretion, subject.
1999
( 25 years old in 2024 )
Mucosal Immunotherapy Platform
-
7171 Frederick-Banting
Montreal, Quebec H4S 1Z9
Canada
Private
developerinflammatory bowel diseasediabetesa flexible nucleotide delivery technologymucosal tissuenumerous prevalent, chronic diseasesuppressionprotein expression levelphysiciandoctorphysiologic, meal-regulate insulin secretionsubject
* We use standard office opening hours in near enGene's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EnGene is Biotechnology business from Canada that founded in 1999 (25 years old in 2024), enGene business is focusing on Mucosal Immunotherapy Platform.
enGene headquarter office and corporate office address is located in 7171 Frederick-Banting Montreal, Quebec H4S 1Z9 Canada.
enGene was founded in Canada.
In 2024, enGene is currently focus on mucosal immunotherapy platform sector.
Above is snippet of Google Trends for "mucosal immunotherapy platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with enGene, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
